학술논문
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults
Document Type
Article
Author
Source
In Clinical Gastroenterology and Hepatology June 2022 20(6):1299-1305
Subject
Language
ISSN
1542-3565